Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir. Thomas M, Hopkins C, Duffy E, Lee D, Loulergue P, Ripamonti D, Ostrov DA, Phillips E (2017) Clin Infect Dis 64: 1198-1203 Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial. Hulgan T, Boger MS, Liao DH, McComsey GA, Wanke CA, Mangili A, Walmsley SL, McCreath H, Milne GL, Sanchez SC, Currier JS, Lake JE (2014) Mediators Inflamm 2014: 803095 Genetic and non-genetic determinants of raltegravir penetration into cerebrospinal fluid: a single arm pharmacokinetic study. Johnson DH, Sutherland D, Acosta EP, Erdem H, Richardson D, Haas DW (2013) PLoS One 8: e82672
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.